Has Akash Patel received payments from drug or device companies?

Yes. Drug and device makers reported $7,686 in general payments to Akash Patel across 85 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Akash Patel did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Akash Patel come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Akash Patel

Internal Medicine · Stratford, NJNPI 1427540236

Payments from drug & device makers

What this record shows

This record is dominated by grants: $4,711 of the $7,686 with a category attached, or 61.3%. Abbott accounts for 74.5% of it on its own, with 21 other manufacturers making up the rest. Among internal medicine clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,686in general payments, 2019–2025

Across 85 payments — averaging $90.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$6K
Kestra Medical Technology Services, Inc.$325
Atricure, Inc.$296
Boston Scientific$271
E.r. Squibb & Sons, L.L.C.$228
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$140
plus $698 from 16 others

What the payments were for

Grants$4,71161%
Food & beverage$2,32030%
Education$6549%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	24	$5,728
Kestra Medical Technology Services, Inc.	9	$325
Atricure, Inc.	4	$296
Boston Scientific	5	$271
E.r. Squibb & Sons, L.L.C.	2	$228
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	3	$140
Amgen	8	$133
Boehringer Ingelheim	7	$112
Abiomed	3	$93
Johnson & Johnson	4	$67
Scpharmaceuticals Inc.	2	$39
Bayer	2	$37
Merck	2	$35
Actelion Pharmaceuticals US, Inc.	2	$35
Heartflow, Inc.	1	$23
Kiniksa Pharmaceuticals International, PLC	1	$20
Daiichi Sankyo Inc.	1	$20
Alnylam Pharmaceuticals Inc.	1	$18
Novartis	1	$18
Cvrx, Inc.	1	$18
Irhythm Technologies, Inc.	1	$17
Novo Nordisk	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ENSITE$718
ASSURITY$577
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$385
TACTICATH$385
CAMZYOS$228
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$153

How this compares

$7,686 in reported general payments places this provider in the 90th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Other internal medicine in Stratford

David ShulkinMorristown$1.7M
Howard UdermanLakewood$955K
Darshi SunderamEast Orange$530K
Annika DrongeEmerson$401K
Stephen MarcellaNew Brunswick$331K
Viju VijaysadanKinnelon$325K
Mark MonaneWoodcliff Lake$268K
Martin BedigianLivingston$240K
Rameck HuntPlainsboro$217K
Angel LazoSecaucus$195K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →